DALLAS, June 6, 2016 /PRNewswire/ -- The Dallas PRP and Stem Cell Institute, a nationally recognized treatment center founded by orthopedic surgeons, announces a new clinical trial that is currently accepting patients. The Institute is now enrolling patients with arthritis in a clinical trial comparing a non steroidal anti-inflammatory medication with Curcumin. Curcumin is an anti-inflammatory plant based herbal supplement that may be safer than NSAIDs like Ibuprofen or Naproxen and as effective as NSAIDs in relieving arthritis pain. The Institute is recognized for providing evidence based regenerative therapies for patients with arthritis and other orthopedic conditions. “The design of our new clinical trial evaluating the supplement Curcumin as a replacement for traditional NSAID medications is a natural result of our overall mission to find safer and less invasive ways to help our bodies heal themselves,” said Don Buford, MD, orthopedic surgeon and founder of the Institute.
Logo - http://photos.prnewswire.com/prnh/20160606/375684LOGO
The Dallas PRP and Stem Cell Institute expects that this new clinical trial will continue to advance the nonsurgical treatment options available to patients with arthritis.
For enrollment questions and more information, please contact the Dallas PRP and Stem Cell Institute’s clinical trial coordinator. The company website at www.dallasprpandstemcell.com contains additional information.
The Dallas PRP and Stem Cell Institute
1015 N. Carroll, Suite 2000
Dallas, Texas 75204
214-385-4861
http://www.dallasprpandstemcell.com
For more information contact:
Sara Reyes, Clinical Coordinator
The Dallas PRP and Stem Cell Institute
214-385-4861
Email
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-dallas-prp-and-stem-cell-institute-announces-new-arthritis-treatment-study-300280000.html
SOURCE The Dallas PRP and Stem Cell Institute
